Previous 10 | Next 10 |
Image source: The Motley Fool. Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Q2 2021 Earnings Call Aug 10, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2021 Earn...
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2021 Earnings Conference Call August 10, 2021, 05:00 PM ET Company Participants Deb Hart - IR Carl Hull - Chairman and CEO Kevin Herde - CFO Conference Call Participants Matt Sykes - Goldman Sachs Tejas Savant - Morgan Stanley Dan Arias - Stifel M...
SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2021, tog...
SAN DIEGO, Aug. 02, 2021 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (“TriLink”), a Maravai LifeSciences company (Nasdaq: MRVI) and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, has enabled Chula Vaccine Research Cente...
libre de droit/iStock via Getty Images Codex DNA ([[DNAY]] +7.4%) signed a licensing and supply agreement with Maravai LifeSciences' ([[MRVI]] +1.8%) TriLink Biotechnologies division for the latter's CleanCap technology. Codex DNA will integrate the mRNA capping technology into its suite...
SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), for its industry-leading CleanC...
SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2021 financial and operating results after the market clo...
Maravai LifeSciences Holdings, Inc. is a leading life sciences company developing and providing critical products for new drug development, diagnostics, novel vaccines, and human disease research. Maravai LifeSciences operates three core businesses including Nucleic Acid Production, B...
SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of June. ...
Maravai LifeSciences (MRVI) has added ~3.2% in the pre-market. Yesterday, after the close, the company announced the outcome of its annual meeting of shareholders for 2021 held on Wednesday.The highlight of the disclosure was the election of four currently serving director...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
2024-07-25 20:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...